Suppr超能文献

《COVID-19 大流行期间排除孕妇参加临床试验:国际注册研究综述》。

Exclusion of Pregnant Women from Clinical Trials during the Coronavirus Disease 2019 Pandemic: A Review of International Registries.

机构信息

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio.

Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio.

出版信息

Am J Perinatol. 2020 Jun;37(8):792-799. doi: 10.1055/s-0040-1712103. Epub 2020 May 19.

Abstract

OBJECTIVE

Pregnant women have been historically excluded from clinical trials for nonobstetric conditions, even during prior epidemics. The objective of this review is to describe the current state of research for pregnant women during the coronavirus disease 2019 (COVID-19) pandemic.

STUDY DESIGN

We conducted a search of international trial registries for trials relating to the novel coronavirus. The eligibility criteria for each trial were reviewed for inclusion/exclusion of pregnant women. Relevant data were extracted and descriptive statistics were calculated for individual and combined data. The total number of trials from each registry were compared, as well as the proportions of pregnancy-related trials within each.

RESULTS

Among 621,370 trials in the World Health Organization International Clinical Trials Registry, 927 (0.15%) were COVID-19 related. Of those, the majority (52%) explicitly excluded pregnancy or failed to address pregnancy at all (46%) and only 16 (1.7%) were pregnancy specific. When categorized by region, 688 (74.2%) of COVID-19 trials were in Asia, followed by 128 (13.8%) in Europe, and 66 (7.2%) in North America. Of the COVID-19 trials which included pregnant women, only three were randomized-controlled drug trials.

CONCLUSION

Approximately 1.7% of current COVID-19 research is pregnancy related and the majority of trials either explicitly exclude or fail to address pregnancy. Only three interventional trials worldwide involved pregnant women. The knowledge gap concerning the safety and efficacy of interventions for COVID-19 created by the exclusion of pregnant women may ultimately harm them. While "ethical" concerns about fetal exposure are often cited, it is in fact unethical to habitually exclude pregnant women from research.

KEY POINTS

· Pregnancy was excluded from past pandemic research.. · Pregnancy is being excluded from COVID-19 research.. · Exclusion of pregnant women is potentially harmful..

摘要

目的

历史上,即使在大流行期间,孕妇也被排除在非产科疾病的临床试验之外。本综述的目的是描述在 2019 冠状病毒病(COVID-19)大流行期间针对孕妇的研究现状。

研究设计

我们对国际临床试验注册库中与新型冠状病毒相关的试验进行了检索。对每个试验的纳入/排除标准进行了审查,以确定是否纳入孕妇。提取了相关数据,并对个体和综合数据进行了描述性统计。比较了每个注册库中的试验总数,以及每个注册库中与妊娠相关的试验比例。

结果

在世界卫生组织国际临床试验注册库的 621370 项试验中,有 927 项(0.15%)与 COVID-19 相关。其中,大多数(52%)明确排除了妊娠或根本没有涉及妊娠(46%),只有 16 项(1.7%)是专门针对妊娠的。按地区分类,688 项(74.2%)COVID-19 试验在亚洲,其次是欧洲 128 项(13.8%),北美 66 项(7.2%)。在纳入孕妇的 COVID-19 试验中,只有 3 项是随机对照药物试验。

结论

目前约有 1.7%的 COVID-19 研究与妊娠有关,大多数试验明确排除或未涉及妊娠。全世界只有三项干预性试验涉及孕妇。由于将孕妇排除在研究之外,可能会对 COVID-19 的干预措施的安全性和有效性产生知识空白,最终可能会对孕妇造成伤害。虽然经常提到对胎儿暴露的“伦理”担忧,但习惯性地将孕妇排除在研究之外实际上是不道德的。

重点

·过去的大流行研究排除了妊娠。·COVID-19 研究正在排除妊娠。·排除孕妇可能有害。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验